Dogwood Therapeutics, Inc. Deferred Income Tax Liabilities, Net
Dogwood Therapeutics, Inc. (DWTX) had Deferred Income Tax Liabilities, Net of $9.20 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-14
- 2026-06-30: Deferred Income Tax Liabilities, Net $9.20M.
- 2026-03-31: Deferred Income Tax Liabilities, Net $11.91M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $12.11M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $11.89M.
| Period end | Deferred Income Tax Liabilities, Net | Deferred Income Tax Liabilities, Net as first filed |
|---|---|---|
| 2026-06-30 | $9.20M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $11.91M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $12.11M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $11.89M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $12.13M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $11.52M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $11.31M 10-K · filed 2026-03-18 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 | $215.62K 10-K · filed 2024-03-01 |
| 2022-12-31 | $340.87K 10-K/A · filed 2024-03-08 | |
| 2021-12-31 | $390.01K 10-K · filed 2023-03-14 | |
| 2020-12-31 | $428.44K 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |